Loading...

RFA-FD-24-040
Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional
Department of Health and Human Services
Food and Drug Administration

General Information

Document Type:Grants Notice
Funding Opportunity Number:RFA-FD-24-040
Funding Opportunity Title:Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Category of Funding Activity:Agriculture
Consumer Protection
Food and Nutrition
Category Explanation:
Expected Number of Awards:1
Assistance Listings:93.103 -- Food and Drug Administration Research
Cost Sharing or Matching Requirement:No
Version:Synopsis 1
Posted Date:May 01, 2024
Last Updated Date:May 01, 2024
Original Closing Date for Applications:Jul 03, 2024
Current Closing Date for Applications:Jul 03, 2024
Archive Date:Aug 02, 2024
Estimated Total Program Funding:$ 7,500,000
Award Ceiling:$7,500,000
Award Floor:$

Eligibility

Eligible Applicants:Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:Duke University

Additional Information

Agency Name:Food and Drug Administration
Description:

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a Cooperative Agreement to the Duke University’s Duke Clinical Research Institute (DCRI) to support the Clinical Trials Transformation Initiative (CTTI).   

Link to Additional Information:RFA-FD-24-040 Funding Opportunity Announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:
Terrin Brown
Grantor